The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Apolipoprotein A-1, Apolipoprotein A1 Cardio IQ, Cardio IQ Apolipoprotein A-1
The Cardio IQ™ Apolipoprotein A-1 test contains 1 test with 1 biomarker.
Brief Description: The Cardio IQ™ Apolipoprotein A-1 test is a specialized blood test designed to assess the levels of Apolipoprotein A-1 (Apo A-1) in the bloodstream. Apo A-1 is a major component of high-density lipoprotein (HDL) cholesterol, often referred to as "good cholesterol."
Also Known As: Apo A1 Test, Apo A-1 Test, Apolipoprotein A-1 Test, A-1 Test
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Fasting for at least 12 hours is required
Apolipoprotein A-I and B, as well as other lipid tests, may be ordered as part of a screening to identify a person's risk of cardiovascular disease.
Apo A-I is a protein that plays a key function in lipid metabolism and is the most abundant protein in HDL, or "good cholesterol." Excess cholesterol in cells is removed by HDL, which transports it to the liver for recycling or elimination. Apo A-I levels tend to rise and fall with HDL levels, and apo A-I deficits are linked to an increased risk of CVD.
Lipids are transported throughout the bloodstream by apolipoproteins, which mix with them. Lipoproteins are held together by apolipoproteins, which protect the water-repellent (hydrophobic) lipids at their core.
Lipoproteins are cholesterol or triglyceride-rich proteins that transport lipids throughout the body for cell absorption. HDL, on the other hand, is like an empty cab. It travels to the tissues to collect excess cholesterol before returning it to the liver. Cholesterol is either recycled for future use or eliminated in bile in the liver. The only mechanism for cells to get rid of excess cholesterol is by HDL reverse transport. It protects the arteries and, if enough HDL is present, it can even reverse the formation of fatty plaques, which are deposits caused by atherosclerosis and can contribute to cardiovascular disease.
The taxi driver is Apolipoprotein A. It permits HDL to be detected and bound by receptors in the liver at the end of the transport by activating the enzymes that load cholesterol from the tissues into HDL. Apolipoprotein A is divided into two types: apo A-I and apo A-II. Apo A-I has a higher prevalence than apo A-II. Apo A-I concentrations can be evaluated directly, and they tend to rise and fall in tandem with HDL levels. Deficiencies in apo A-I are linked to an increased risk of cardiovascular disease.
When a Cardio IQ Apolipoprotein A1 test is ordered, it's often part of a broader evaluation of lipid metabolism and cardiovascular health. Here are some tests commonly ordered alongside it:
High-Sensitivity C-Reactive Protein (hs-CRP):
Fasting Blood Glucose and Hemoglobin A1c (HbA1c):
These tests, when ordered alongside a Cardio IQ Apolipoprotein A1 test, provide a comprehensive view of cardiovascular health and lipid metabolism. They are crucial for accurately assessing cardiovascular risk and guiding the management of dyslipidemia and other related conditions. The specific combination of tests will depend on the individual’s risk factors, health status, and family history.
The Cardio IQ™ Apolipoprotein A-1 test is used to assess cardiovascular risk and is not specifically tied to a single disease. It helps healthcare providers identify individuals at risk of developing heart disease, stroke, and other cardiovascular conditions.
An apo B/apo A-I ratio can be determined by ordering both an apo A-I and an apo B test. To assess the risk of developing CVD, this ratio is sometimes used instead of the total cholesterol/HDL ratio.
An apo A-I test may be ordered in the following situations:
Assist in the diagnosis of apo A-I deficiency caused by genetic or acquired diseases.
Assist those with a personal or family history of heart disease, high cholesterol, or triglycerides in their blood.
Keep track of how well lifestyle changes and lipid therapies are working.
An apo A-I test can be ordered in conjunction with an apo B test to determine the apo B/apo A-I ratio. This ratio is occasionally used instead of the total cholesterol/HDL ratio (which is sometimes included in a lipid profile) to assess the risk of developing CVD.
Low apo A-I levels are linked to low HDL levels and slowed elimination of excess cholesterol from the body. Low levels of apo A-I, as well as high levels of apo B, are linked to a higher risk of cardiovascular disease.
Deficiencies in apo A-I are caused by a number of hereditary diseases. Abnormal lipid levels, notably excessive amounts of low-density lipoprotein, are common in people with certain illnesses. They frequently have a higher rate of atherosclerosis. Low apo A-I levels are caused by several genetic diseases.
What is the main purpose of the Cardio IQ™ Apolipoprotein A-1 test?
The Cardio IQ™ Apolipoprotein A-1 test measures the level of Apolipoprotein A-1 (Apo A-1) in the blood. Apo A-1 is the primary protein associated with HDL cholesterol, often referred to as "good cholesterol." The test can provide insight into a person's risk for cardiovascular diseases, with lower levels suggesting a higher risk.
How do the results of the Cardio IQ™ Apolipoprotein A-1 test correlate with cardiovascular risk?
Higher levels of Apolipoprotein A-1 generally indicate a lower risk of cardiovascular disease since Apo A-1 helps remove cholesterol from the bloodstream. Conversely, lower levels might signify a higher risk. However, the test should be considered alongside other cholesterol tests and risk factors to provide a comprehensive understanding of cardiovascular risk.
How does the Cardio IQ™ Apolipoprotein A-1 test fit into the larger picture of cardiovascular risk assessment?
While traditional lipid panel tests (like LDL, HDL, total cholesterol, and triglycerides) are foundational for assessing cardiovascular risk, the Cardio IQ™ Apolipoprotein A-1 test can offer additional insight, especially if traditional tests present conflicting or ambiguous results. It's part of a newer generation of tests providing more nuanced information about heart health.
Can the Cardio IQ™ Apolipoprotein A-1 test be used to monitor the effects of treatment on cardiovascular risk?
Yes, the test can be used to gauge the effectiveness of treatments aimed at raising HDL cholesterol levels. If Apo A-1 levels increase with treatment, it might indicate the treatment's effectiveness in enhancing cardiovascular protection.
How does the Cardio IQ™ Apolipoprotein A-1 test differ from a standard HDL cholesterol test?
While both tests assess factors related to HDL cholesterol, they measure different things. The standard HDL test measures the amount of HDL cholesterol in the blood, whereas the Cardio IQ™ Apolipoprotein A-1 test measures the primary protein component of HDL cholesterol. Some experts believe that Apo A-1 levels might provide a more accurate representation of the functional capability of HDL particles in the blood.
Are there conditions other than cardiovascular diseases that can affect Apolipoprotein A-1 levels?
Yes, various conditions can influence Apo A-1 levels, including genetic factors, liver diseases, kidney diseases, and some inflammatory conditions. It's crucial to interpret the Cardio IQ™ Apolipoprotein A-1 test results in the context of the individual's overall health and other diagnostic information.
Does diet or lifestyle affect the levels of Apolipoprotein A-1?
Yes, a healthy diet rich in omega-3 fatty acids (like from fish), regular physical activity, and moderate alcohol consumption (especially red wine) have been associated with higher Apo A-1 levels. On the other hand, smoking and obesity can lead to reduced Apo A-1 levels.
Is there an optimal range for Apolipoprotein A-1 levels, and how does it differ across populations?
The optimal range for Apolipoprotein A-1 can vary based age, gender and ethnicity, but generally, higher levels are more favorable in terms of cardiovascular risk. It's essential to consider factors like age, gender, and ethnicity when interpreting results, as Apo A-1 levels can vary across populations.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.